Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y
Yahoo/Zacks.com
Sat, 02/23/19 - 04:03 pm
Tags:
Bluebird Bio, earnings
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Tags:
Biogen, Bluebird Bio, Global Blood Therapeutics, Aimmune Therapeutics, Vertex Pharmaceuticals, Sarepta Therapeutics
Where Will bluebird bio Be in 5 Years?
Motley Fool
Thu, 01/24/19 - 11:41 am
Tags:
Bluebird Bio, LentiGlobin, bb21217, CAR-T
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Tags:
Celgene, M&A, Juno Therapeutics, Kite Therapeutics, Bluebird Bio, Agios Pharmaceuticals, Jounce Therapeutics, BieGene, Acceleron
bluebird's five-year pricing model for LentiGlobin could resonate with payers
BioCentury
Wed, 01/9/19 - 09:21 am
Tags:
Bluebird Bio, LentiGlobin, Medicaid, drug pricing, payers
Here's Why bluebird bio Shares Got Knocked Down 19.3% in December
Motley Fool
Sat, 01/5/19 - 12:05 am
Tags:
Bluebird Bio, ASH2018, AMG 420, Amgen
Six Things to Watch for at the JP Morgan Healthcare Conference
BioSpace
Fri, 01/4/19 - 10:35 am
Tags:
Moderna Therapeutics, Sarepta Therapeutics, Biogen, Gilead Sciences, Bluebird Bio
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
Tags:
clinical trials, Alzheimer's disease, Biogen, Duchenne Muscular Dystrophy, Pfizer, Solid Biosciences, Sarepta Therapeutics, hemophilia A, Biomarin, Multiple Myeloma, Celgene, Bluebird Bio, Amgen, solid tumors, Bristol-Myers Squibb, Nektar Therapeutics, age-related macular degeneration, Regenxbio, SAGE Therapeutics, MorphoSys
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Motley Fool
Wed, 12/5/18 - 11:54 am
Tags:
Celgene, Bluebird Bio, bb21217
ASH18: New data can’t lift Bluebird Bio’s depressed shares
Fierce Biotech
Tue, 12/4/18 - 10:02 am
Tags:
Bluebird Bio, ASH 2018
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
Tags:
ASH2018, Bluebird Bio, CAR-T, bb21217
Top Biotech Stocks to Watch at ASH 2018
Yahoo/Motley Fool
Sun, 12/2/18 - 12:37 pm
Tags:
ASH2018, Celgene, Bluebird Bio, Acceleron
Waiting for bluebird bio to Sing at ASH
Motley Fool
Sat, 11/10/18 - 12:05 pm
Tags:
Bluebird Bio, earnings, ASH, CAR-T
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Tags:
Acceleron, luspatercept, Bluebird Bio, bb21217, Amgen, AMG 420
Here's Why bluebird bio Dropped 13.3% in September
Motley Fool
Thu, 10/11/18 - 10:54 pm
Tags:
Bluebird Bio, Amgen
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
CP Wire
Fri, 10/5/18 - 09:50 am
Tags:
Bluebird Bio, transfusion-dependent anemia, LentiGlobin, EMA, Europe
Fri, 10/5/18 - 09:18 am
Tags:
Bluebird Bio, transfusion-dependent anemia, LentiGlobin
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Tags:
Bluebird Bio, Amgen, Celgene, AMG-420, bb2121
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Tags:
Adamis, GSK, Sangamo BioSciences, Roche, Bluebird Bio, ProQR Therapeutics, Geron, Amarin, Palatin, EyeGate, Galactin, Omeros, Atossa Genetics
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Thu, 08/23/18 - 11:04 am
Tags:
Bluebird Bio, Gritstone Oncology, oncology, T-cell receptors, drug development

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.